Suppr超能文献

仰卧或俯卧位爬行光子或质子乳房和区域淋巴结放疗,包括内乳链。

Comparison of supine or prone crawl photon or proton breast and regional lymph node radiation therapy including the internal mammary chain.

机构信息

Department of Radiotherapy and Experimental Cancer Research, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.

Paul Scherrer Institut, Villigen, Switzerland.

出版信息

Sci Rep. 2019 Mar 18;9(1):4755. doi: 10.1038/s41598-019-41283-1.

Abstract

We report on a dosimetrical study comparing supine (S) and prone-crawl (P) position for radiotherapy of whole breast (WB) and loco-regional lymph node regions, including the internal mammary chain (LN_IM). Six left sided breast cancer patients were CT-simulated in S and P positions and four patients only in P position. Treatment plans were made using non-coplanar volumetric modulated arc photon therapy (VMAT) or pencil beam scanning intensity modulated proton therapy (IMPT). Dose prescription was 15*2.67 Gy(GyRBE). The average mean heart doses for S or P VMAT were 5.6 or 4.3 Gy, respectively (p = 0.16) and 1.02 or 1.08 GyRBE, respectively for IMPT (p = 0.8; p < 0.001 for IMPT versus VMAT). The average mean lung doses for S or P VMAT were 5.91 or 2.90 Gy, respectively (p = 0.002) and 1.56 or 1.09 GyRBE, respectively for IMPT (p = 0.016). In high-risk patients, average (range) thirty-year mortality rates from radiotherapy-related cardiac injury and lung cancer were estimated at 6.8(5.4-9.4)% or 3.8(2.8-5.1)% for S or P VMAT (p < 0.001), respectively, and 1.6(1.1-2.0)% or 1.2(0.8-1.6)% for S or P IMPT (p = 0.25), respectively. Radiation-related mortality risk could outweigh the ~8% disease-specific survival benefit of WB + LN_IM radiotherapy for S VMAT but not P VMAT. IMPT carries the lowest radiation-related mortality risks.

摘要

我们报告了一项比较仰卧位(S)和俯卧位爬行(P)体位进行全乳(WB)和局部区域淋巴结区域(包括内乳链(LN_IM))放射治疗的剂量学研究。6 名左侧乳腺癌患者在 S 和 P 位置进行 CT 模拟,4 名患者仅在 P 位置进行模拟。使用非共面容积调制弧形光子治疗(VMAT)或笔形束扫描强度调制质子治疗(IMPT)制定治疗计划。处方剂量为 15*2.67 Gy(GyRBE)。S 或 P VMAT 的平均心脏剂量分别为 5.6 或 4.3 Gy(p = 0.16),IMPT 的平均心脏剂量分别为 1.02 或 1.08 GyRBE(p = 0.8;p < 0.001 与 VMAT 相比)。S 或 P VMAT 的平均肺剂量分别为 5.91 或 2.90 Gy(p = 0.002),IMPT 的平均肺剂量分别为 1.56 或 1.09 GyRBE(p = 0.016)。在高危患者中,估计 S 或 P VMAT 放疗相关心脏损伤和肺癌 30 年死亡率分别为 6.8(5.4-9.4)%或 3.8(2.8-5.1)%(p < 0.001),S 或 P IMPT 分别为 1.6(1.1-2.0)%或 1.2(0.8-1.6)%(p = 0.25)。S VMAT 的放疗相关死亡率风险可能超过 WB + LN_IM 放疗的 8%左右疾病特异性生存获益,但 P VMAT 则不然。IMPT 带来的放疗相关死亡率风险最低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9822/6427000/d7b9c1505ac3/41598_2019_41283_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验